Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = -70 % | Allosteric enhancer activity at recombinant human A1 adenosine receptor expressed in CHO cells assessed as change in forskolin-induced cAMP production at 10 uM after 6 mins by radioimmunoassay | ChEMBL. | 22182575 |
Activity (functional) | = -39 % | Allosteric enhancer activity at recombinant human A1 adenosine receptor expressed in CHO cells assessed as change in forskolin-induced cAMP production at 1 uM after 6 mins by radioimmunoassay | ChEMBL. | 22182575 |
Activity (functional) | = -6.2 % | Allosteric enhancer activity at recombinant human A1 adenosine receptor expressed in CHO cells assessed as change in forskolin-induced cAMP production at 0.1 uM after 6 mins by radioimmunoassay | ChEMBL. | 22182575 |
Activity (functional) | = 6.1 % | Allosteric enhancer activity at recombinant human A1 adenosine receptor expressed in CHO cells assessed as change in forskolin-induced cAMP production at 0.01 uM after 6 mins by radioimmunoassay | ChEMBL. | 22182575 |
Inhibition (binding) | = 0 % | Displacement of [3H]MRE3008F20 from recombinant human A3 adenosine receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting | ChEMBL. | 22182575 |
Inhibition (binding) | = 0 % | Displacement of [3H]ZM241385 from recombinant human A2A adenosine receptor expressed in CHO cells at 10 uM after 60 mins by scintillation counting | ChEMBL. | 22182575 |
Inhibition (binding) | = 0 % | Displacement of [3H]DPCPX from recombinant human A1 adenosine receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting | ChEMBL. | 22182575 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.